JournalArta
IDEN · GLOBAL
Sunday, November 8, 2026 · JakartaS&P 7,376.86 ▲0.32%USD/IDR 18,004 ▼0.25%Subscribe
JournalArta
Global Edition
beyond headlines

#Lung Cancer — JournalArta Global

Advertisement
Business

Roche’s Divarasib Cut Death Risk 44% in Lung Cancer Trial

Oct 26
Business

Amgen Combo Cuts Death Risk 58% in Lung Cancer Trial

Oct 25
World

Australia’s lung cancer screening program spots tumours earlier, offering patients a better shot at treatment

Aug 28
Advertisement